Clinical Trials Browser

Peripheral Nervous System Diseases × enfortumab vedotin × 30 days × Clear all

NCT07484022 2026-03-19

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Not yet recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases